[Frontiers in Bioscience E2, 361-368, January 1, 2010]

Mitochondrial DNA damage analysis in bronchoalveolar lavage cells of preterm infants

Bea Zoer1, Jasper Been1, Eveline Jongen2, Anne Debeer3, Alexandra Hendrickx2, Hubertus Smeets2, Luc Zimmermann1, Eduardo Villamor 1

1Department of Pediatrics Maastricht University Medical Center (MUMC+), GROW School for Oncology and Developmental Biology, 6202 AZ Maastricht, The Netherlands, 2Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), GROW School for Oncology and Developmental Biology, 6202 AZ Maastricht, The Netherlands, 3Department of Neonatology, University Hospital Gasthuisberg, 3000 Leuven, Belgium

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. Patients and methods
3.1. BAL-cell collection and processing
3.2. Detection of deletions in the mitochondrial genome
3.3. Mutation detection in the mitochondrial D-loop
3.4. mtDNA copy number analysis
4. Results
5. Discussion
6. Acknowledgements
7. References

1. ABSTRACT

In mechanically ventilated preterm infants, the combination of immaturity, volutrauma, oxidative stress, and inflammatory processes can lead to chronic lung injury. Mitochondrial DNA (mtDNA) is more susceptible to oxidative damage than nuclear DNA. We aimed to investigate the level of mtDNA damage (deletions, mutations and changes in copy number) in bronchoalveolar lavage (BAL) cells from 10 preterm infants (27-30 weeks). A first BAL (BAL1) was done within 24 h of endotracheal intubation and BAL2 was performed 30-103 h thereafter. Deletions were analyzed by long range PCR, point mutations by heteroduplex analysis of the D-loop region, and copy number changes by real-time PCR. Using these methods, no deletions were found in any of the BAL samples. When BAL1 and BAL2 samples were compared no new mutations were found. In contrast, a marked decrease in mtDNA copy number was observed in 5 patients. In conclusion, we found that exposure of preterm infants to short term mechanical ventilation did not lead to detrimental consequences for the mtDNA in the form of mutations or deletions.

2. INTRODUCTION

In mechanically ventilated preterm infants, immaturity in combination with oxidative stress, volutrauma, and inflammatory processes can lead to chronic lung injury (1-6). Oxidative damage is found very early in infants subsequently developing chronic lung disease and knowledge is now accumulating on how reactive oxygen species (ROS) trigger cellular and molecular changes that may impair normal pulmonary growth and development (1, 2).

Mitochondrial DNA (mtDNA) is more susceptible to oxidative damage and consequently acquires mutations at a higher rate than nuclear DNA (7). This is due to exposure to high levels of ROS generated during respiration, lack of protective histones, and limited capacity for repair of DNA damage (8). Significant damage to mtDNA will compromise cellular respiration, resulting in elevated levels of ROS that cause further injury to mitochondrial and nuclear DNA and, therefore, potentially contribute to chronic lung disease (8, 9). In this study, we hypothesized that mechanical ventilation would induce mtDNA damage in the lung of preterm infants. To test our hypothesis, we conducted a pilot study evaluating mtDNA deletions, mutations and changes in copy number in bronchoalveolar lavage (BAL) cells from preterm infants following endotracheal intubation and within 2-4 days of mechanical ventilation.

3. PATIENTS AND METHODS

The study was approved by the Maastricht University Medical Centre Ethics Committee and fully informed, written consent was obtained from the parents of each infant. The study population consisted of ten intubated, mechanically-ventilated preterm infants, whose clinical information is summarized in table 1. The information about the characteristics of the mechanical ventilation used during the study period is summarized in table 2. The ten children received surfactant (Curosurf 200 mg/kg; Chiesi Farmaceutica, Parma, Italy) within 2h after birth and at least 6 h before the first BAL. Patients1, 8, 9, and 10 received a second surfactant dose between the two BAL procedures.

3.1. BAL-cell collection and processing

A first BAL (BAL1) was done within 24 h of endotracheal intubation and a second (BAL2) was performed 30-103 h (median 48.5 h) thereafter. BAL was performed as previously described (10). Briefly, with the infant lying supine and the head turned to the left, a 6 F suction catheter was gently inserted into the endotracheal tube until resistance was felt. Then, 1ml/kg birth weight of sterile isotonic saline was gently infused into the lung. After 5 s, suctioning was performed while slowly retracting the catheter. The procedure was repeated once after which the collected fluid was pooled and placed on ice. From the pooled aspirate, aliquots were taken for total and differential cell count. Haemocytometer counting was used to obtain total cell counts per ml of BAL fluid and a differential cell count was performed on cytospins of BAL cells using May-Grünwald-Giemsa stain. 500 cells were counted on each cytospin. The remainder of the BAL fluid was centrifuged at 300 x g for 10 minutes at 4 �C and the supernatant and the cells were stored at -80�C until analysis. All subsequent analyses were done by investigators who were blinded to the clinical features of the patients.

3.2. Detection of deletions in the mitochondrial genome

Total DNA was isolated according to the manufacturer's procedure using the QIAmpR DNA mini kit from Qiagen. A deletion PCR was performed for the whole mitochondrial DNA. Two primer pairs were used, yielding two mtDNA fragments of 16.1 and 16.0kb in size, respectively. Primer sequences for fragment one were 5'-CCGCTTCTGGCCACAGCACTTAAACACATC-3', at location 0314-0343, and 5'-GGAGGATGGTGGTCAAGGGACCCCTATCTG-3', at location 16411-16382. For fragment 2 primers 5'-CAAGGTGTAGCCCATGAGGTGGCAAG-3', located at 01330-01355, and 5'-GCTGCATTGCTGCGTGCTTGATG-3', located at 00778-00756, were used. The PCR mix consisted of Expand Long Template buffer (10x; 27.5mM MgCl2), dNTP-mix containing 8.33mM of each base, 100ng per microliter forward and reverse primer, 5U per microliter Expand Long Polymerase and 50ng of DNA in a total volume of 50 microliter. The PCR was performed using a PCR Perkin Elmer type 9700. First denaturation was achieved at 98° C for 30 s, followed by 30 cycles of 10 s of denaturation at 98° C and 8 min 15 s annealing at 72° C, followed by 10 min of elongation at 72° C. The PCR products were stored at 4° C until use. 25 microliter PCR-products were loaded on ethidium bromide stained 0.7% agarose gels in TAE-buffer and run for 16 hours at 32V. After 16 hours a picture was taken of the PCR products in the gel and the gel was run for another 16 hours at 32V. Samples from the DNA bank of our institution were used as controls. The positive control was DNA obtained from muscle tissue of a 45-year-old female, whose mtDNA contained several deletions as a consequence of aging. The negative control was a DNA sample without mtDNA deletions.

3.3. Mutation detection in the mitochondrial D-loop

Another set of PCRs was performed to yield three fragments (fragment 1, 2 and 3 from the MitoScreenTM Assay Kit, Transgenomic, Elancourt, France ) spanning the mutation hot spot D-loop region of the mtDNA, that were subjected to denaturing HPLC (DHPLC) analysis. The first primer pair (5'-CTCCACCATTAGCACCCAAAGC-3' and 5'-GAGGATGGTGGTCAAGGGACC-3') was used to amplify the region between 15974-16409bp, the second primer pair (5'TACAGTCAAATCCCTTCTCGTCC-3' and 5'-TCCAGCGTCTCGCAATGCTATC-3') was used to amplify the region between 102-16341bp, and the third primer pair (5'-CTCACGGGAGCTCTCCATGCAT-3' and 5'-ATTAGTAGTATGGGAGTGGGAGG-3') was used to amplify the region between 29-480 bp. The PCR mix contained 10* Optimase® reaction buffer with MgSO4, dNTP mix containing 10mM of each dNTP, Optimase Polymerase 2.5U, 100ng DNA, and 100ng of both primers in a total volume of 50μl. The PCR was performed using a Thermocycler (Perkin Elmer type 9700). Denaturation was achieved at 95° C for 2 min, then the samples were subjected to 30 cycles of 30 s of denaturation at 95° C, 30 s of annealing at 56° C, 3 min of elongation at 72° C, followed by 5 min of elongation at 72° C. PCR products were stored at 4° C until use. Heteroduplex formation was achieved by heating the PCR products at 95° C for 5 min. Then the samples were cooled at a rate of 1.5° C/min until a temperature of 25° C was reached. Next, the samples were placed in the WAVEâ nucleic acid fragment analysis system for analyses. The DNA was initially mixed with tri-ethyl ammonium acetate, which functions as an ion pairing reagent. This enables size based binding of the hydrophilic DNA to the hydrophobic DNASepâ Matrix. Heat was used as a denaturant, in conjunction with the hydrophobic eluant acetonitrile, which lead to elution of the DNA from the matrix according to helicity and size. DNA containing a heteroduplex (and thus a mutation) will elute earlier from the matrix than the homoduplex species. In this way the chromatogram pattern changes and the presence of a mutation can be detected. WAVEâ Control Standards were used to ensure quality during the analysis. This includes the WAVE DNA Sizing Control Sample, the Low Range Mutation Control Standard, the Mid Range Mutation Control Sample and the High Range Mutation Control Standard. The temperatures at which 8μl of the PCR products was analyzed by DHPLC were optmized for each individual fragment: 50° C and 58° C for fragment 1, 50° C and 60° C for fragment 2 and 50° C, 57° C and 59° C for fragment 3. The resulting chromatograms from BAL1 and BAL2 were compared between each other and with standards.

3.4. mtDNA copy number analysis

To analyze potential changes in copy number of mtDNA as a consequence of mechanical ventilation, Real-Time PCR was performed for the nuclear RNase P gene and the mtDNA encoded 12S-RNA gene. The PCR mix contained Taqman Universal PCR Master Mix, TaqManR RNase P Control Reagents Kit (VICTM Probe), primers 12S (3'-CCCCAGGGTTGGTCAATTT-5' and 3'-CTATTGACTTGGGTTAATCGTGTGA-5') and TaqmanR probe 12S (3'-TGCCAGCCACCGCG-5') 6pmol. The PCR was performed in an ABI Prism 7000 Sequence Detection System. Amplitaq Gold activation was obtained at 95° C for 10 minutes, followed by 40 cycles of denaturation for 15 s at 95° C and annealing and extension at 60° C for 1 min. A standard DNA dilution was made to plot a standard curve to determine the efficiency of the PCR. Every sample was analyzed in duplicate. The efficiency was calculated by the formula Eff = 10-1/slope. Relative copy number (Rc) was calculated by expressing threshold cycle number differences of the nuclear gene and the mitochondrial gene PCR, as described by Ritov et al (11): Rc=2(Ct nDNA-Ct mtDNA), where Ct is the threshold cycle number.

4. RESULTS

Total and differential BAL cell counts are presented in Table 3. More detailed BAL cytospin data from patient 3, who experienced severe pneumonia, have previously been reported (12). When the mtDNA of the BAL cells was screened for deletions none of the samples showed positive results. Figure 1 shows an example of the PCR products that were exposed to gel electrophoresis for 32 h. The positive control shows several bands, which indicate deletions in the DNA of this sample (muscle tissue from a 45-year-old female, whose mtDNA contained several deletions as a consequence of aging). In contrast, no extra bands are observed in the mtDNA of BAL1 and BAL2 samples, as well as in the negative control.

When BAL1 and BAL2 samples were compared, no newly formed mutations in the D-loop of the mtDNA were observed. Figure 2 shows an example of the DHPLC-output from BAL1 and BAL2 DNA of two children. As can be seen in the figure, no new heteroduplexes were found in the analyzed products.

The results of the mtDNA copy number analysis are presented in Table 4. One of the samples was not successfully amplified despite the availability of ample genetic material. Five of the BAL2 samples analyzed showed a decrease in the relative mtDNA copy number when compared to the corresponding BAL1. Two of the samples showed no change and two showed an increase in mtDNA copy number. The efficiency of this PCR was 1.97.

5. DISCUSSION

Documentation of mtDNA damage in vivo after acute insults is sparse compared with the number of in vitro studies that have demonstrated oxidative injury to mtDNA (13). To the best of our knowledge, this is the first study addressing the putative mtDNA damage induced by mechanical ventilation in humans. We observed, in a population of ten preterm infants, that 2-4 days of mechanical ventilation with oxygen concentrations up to 100%, and in some cases in combination with NO, did not induce any detectable mutation or deletion in the mtDNA isolated from BAL cells. However, in five of the samples a decrease in mtDNA copy number was detected.

Our findings raise several points of discussion. First of all, whether the methods used are sensitive enough to detect mtDNA deletions and mutations. The deletion PCR we constructed is considered as a sensitive method with a detection limit of 0.5-1% (14, 15). Single base mutations in mtDNA can not be detected by deletion PCR. Therefore we performed heteroduplex analysis using the DHPLC method (16, 17) to screen the D-loop region (a mutation hot spot region in the mtDNA) (18). This method has a 97-100% efficiency of mutation detection (confirmed by sequencing the abnormal PCR-products) and a threshold of 1-5% for detection of a specific mutation (16, 17). Mutations can randomly occur across the DNA fragments and it can be expected that each mutation would eventually lead to a heteroduplex and an altered migration pattern producing altered peak or peaks, which would contain mixtures of different mutations. Differences in these peak patterns were not observed when BAL1 and BAL2 samples were compared, indicating that new mutations were not present. Other techniques, with very high sensitivity for mutation detection have been recently described. One mutation among 109 bases can be detected with the random mutation capture (RMC) method (19, 20). Whether this method could detect mutations that we did not find with the DHPLC method remains to be investigated.

Also the intensity and duration of the insult in the studied population could be related to our negative results. It can be argued that higher levels of or longer exposures to oxidative stress would be necessary to induce mtDNA deletions or mutations. The majority of the patients in our population were exposed to high concentrations of oxygen at birth, when resuscitation was performed. A preceding hypoxic period appeared to be present in four cases (Table 1) Afterwards, between the two moments of sampling, patients were generally exposed to gentle mechanical ventilation and the majority did not need oxygen-rich gas. With the advent of surfactant therapy and the widespread use of antenatal steroids, the clinical picture of infant RDS changed considerably (1). Nowadays, preterm newborns often require little supplemental oxygen during their initial postnatal course, and it is uncommon for such infants to receive mechanical ventilation with high inflation pressures or large tidal volumes (1). Interestingly, it has been suggested that the inflammatory response is more likely than hyperoxia to lead to pulmonary oxidative damage in mechanically ventilated preterm infants (5). On the other hand, our understanding of the ill effects of brief oxygen exposure at birth has been increased significantly and it has been shown that hyperoxia, even for short periods and particularly following a previous hypoxic insult, contributes to the development of several neonatal morbidities (1, 2, 21-23). In this regard, oxygen administration in the delivery room has become a matter of discussion in the last years (21-24). Moreover, an association has been suggested between the DNA damage induced by post-hypoxic neonatal exposure to high oxidative stress and childhood cancer (23, 25, 26). In the present work, we analyzed mtDNA, which is more susceptible to oxidative damage than nuclear DNA (7). However, our data suggest that in a normal clinical setting of mechanical ventilation DNA deletions or mutations are not produced or, alternatively, they have been repaired, although repair systems are less efficient for the mtDNA than for the nuclear DNA (7, 8).

There is overwhelming evidence from in vitro studies that oxidative stress damages DNA (7, 8, 27). Also, in vivo experimental studies using exposure to hyperoxia in premature baboons (28) neonatal rats (29), adult rats (30, 31) and adult mice (32) demonstrated pulmonary oxidative nuclear DNA damage. The urinary levels of 8-hydroxy-2′-deoxyguanosine, a marker of oxidative DNA damage, were significantly higher in preterm infants requiring supplemental oxygen and ventilator support than in non-mechanically ventilated preterm and healthy term neonates (33). To the best of our knowledge, only one study has analyzed pulmonary mtDNA integrity after in vivo hyperoxic exposure (13). In consonance with our results, Lightfoot et al. observed that hyperoxia (24-48 h of 95% oxygen in adult rats) failed to induce significant injury to mtDNA and only when combined with NO inhalation transient mtDNA damage was produced. They speculate that efficient removal of ROS by mitochondrial antioxidant systems or upregulation during hyperoxia of mtDNA repair systems may be the explanation for the lack of injury in the mtDNA (13).

In five cases, we found a decrease in the relative mtDNA copy number between BAL1 and BAL2. With our limited sample size, we can only speculate about this finding. As different cell types contain different amounts of mtDNA, our finding may simply reflect the differences in BAL cell composition between the two moments of sampling. The majority of the studies dealing with the effects of oxidant stress on mtDNA copy number have been focused on chronic exposure to the insult and they demonstrated an increase in the copy number (see 8 for a review). This has been suggested to be a compensatory mechanism for defective mitochondria bearing impaired respiratory chain or mutated mtDNA (8). Because ROS generation by the mitochondrial respiratory chain is a continuous physiological occurrence, mitochondria have an efficient antioxidant system composed of superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione, NAD(P) transhydrogenase, NADPH, vitamins E and C, thiol peroxidases and mitochondrial respiration itself (34, 35). However, when the capacity of antioxidant system is compromised, the exposure to higher oxidative stress may result in an increase of defective mitochondria beyond a non-compensable level and thus, a cyclic increase in ROS production leading to mitochondrial lipid peroxidation and a decrease in mtDNA copy number (8, 27, 36). This could drive the cell into an irreversible cell death process (8, 37) that would lead to an increase in extracellular mtDNA with proinflammatory effects, thereby creating a vicious circle of inflammation and cell destruction (38). Although it is generally accepted that extracellular and cytosolic antioxidant defenses are reduced in preterm infants (2, 4), this has not been demonstrated for the mitochondrial antioxidant system. Therefore, the putative maturational changes in the mitochondrial antioxidant and DNA reparation systems and their possible role in chronic lung disease require further investigation.

Although the pathogenesis of chronic lung disease of the premature infant remains unclear, much evidence suggests that reflects abnormal growth and repair of the immature lung exposed to the continuous stress of repetitive inflation with oxygen -rich gas in a setting of chronic inflammation, often aggravated by recurrent infection (1). An important part of these pathogenetic insights has been obtained through the analysis of BAL fluid and cells (3-6, 10, 12, 39). Our pilot study proposes a new approach for the evaluation of lung injury and shows that the analysis of BAL cell mtDNA is feasible tool for testing the putative effects of oxidative stress during mechanical ventilation. However, and against our initial hypothesis, we could not find any detectable mtDNA mutation or deletion. The validity of our findings is limited by several factors such as the sample size, the relative inhomogeneity of the sample, the lack of parallel measurement of other oxidative stress markers, or the relative short exposure to the oxidative stimulus. The idea of our study was based on three generally accepted paradigms: I) Preterm newborns are very susceptible to oxidative stress (2, 4, 21, 23, 24, 33); II) Oxidative stress plays a significant role in the pathophysiology of ventilator-induced injury (1, 2, 4); and III) mtDNA is highly vulnerable to oxidative stress (7-9). Further studies including larger samples, which include longer periods and different strategies of mechanical ventilation, as well as different methods to evaluate mtDNA damage and function will be needed to assess whether the above paradigms also apply to the real clinical situation of mechanically-ventilated preterm infants.

6. ACKNOWLEDGEMENTS

We thank C.F.M. Linssen from the department of Medical Microbiology for her technical assistance with differential cell count. This work was supported by a grant of "Stichting Sint Annadal".

7. REFERENCES

1. Bland, R. D.: Neonatal chronic lung disease in the post-surfactant era. Biol Neonate, 88, 181-91(2005)
doi:10.1159/000087581
PMid:16210840

2. Saugstad, O. D.: Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol, 8, 39-49(2003)
doi:10.1016/S1084-2756(02)00194-X
PMid:12667829

3. Capoluongo, E., F. Ameglio, P. Lulli, A. Minucci, C. Santonocito, P. Concolino, E. Di Stasio, S. Boccacci, V. Vendettuoli, G. Giuratrabocchetta, A. De Cunto, M. Tana, C. Romagnoli, C. Zuppi & G. Vento: Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants. Am J Physiol Endocrinol Metab, 292, E308-13(2007)
doi:10.1152/ajpendo.00251.2006

4. Vento, G., M. C. Mele, A. Mordente, C. Romagnoli, P. G. Matassa, E. Zecca, B. Zappacosta & S. Persichilli: High total antioxidant activity and uric acid in tracheobronchial aspirate fluid of preterm infants during oxidative stress: an adaptive response to hyperoxia? Acta Paediatr, 89, 336-42(2000)
doi:10.1080/080352500750028492
PMid:10772283

5. Collard, K. J., S. Godeck, J. E. Holley & M. W. Quinn: Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch Dis Child Fetal Neonatal Ed, 89, F412-6(2004)
doi:10.1136/adc.2002.016717
PMid:15321959    PMCid:1721746

6. De Luca, D., S. Baroni, G. Vento, M. Piastra, D. Pietrini, F. Romitelli, E. Capoluongo, C. Romagnoli, G. Conti & E. Zecca: Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med, 34, 1858-64(2008)
doi:10.1007/s00134-008-1224-3
PMid:18648767

7. Yakes, F. M. & B. Van Houten: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A, 94, 514-9(1997)
doi:10.1073/pnas.94.2.514

8. Lee, H. C. & Y. H. Wei: Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol, 37, 822-34(2005)
doi:10.1016/j.biocel.2004.09.010

10. Dik, W. A., L. J. Zimmermann, B. A. Naber, D. J. Janssen, A. H. van Kaam & M. A. Versnel: Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant. Pediatr Pulmonol, 35, 34-41(2003)
doi:10.1002/ppul.10219
PMid:12461737

11. Ritov, V. B., E. V. Menshikova, J. He, R. E. Ferrell, B. H. Goodpaster & D. E. Kelley: Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes, 54, 8-14(2005)
doi:10.2337/diabetes.54.1.8
PMid:15616005

12. Been, J. V., C. F. Linssen, J. F. van Iwaarden & L. J. Zimmermann: Massive bacterial cell invasion and reactive type II pneumocytes in bronchoalveolar lavage fluid from a preterm neonate. Arch Dis Child Fetal Neonatal Ed, 92, F319(2007)
doi:10.1136/adc.2006.108167
PMid:17585099

13. Lightfoot, R. T., S. Khov & H. Ischiropoulos: Transient injury to rat lung mitochondrial DNA after exposure to hyperoxia and inhaled nitric oxide. Am J Physiol Lung Cell Mol Physiol, 286, L23-9(2004)
doi:10.1152/ajplung.00352.2002

14. Tengan, C. H. & C. T. Moraes: Detection and analysis of mitochondrial DNA deletions by whole genome PCR. Biochem Mol Med, 58, 130-4(1996)
doi:10.1006/bmme.1996.0040
PMid:8809354

15. De Coo, I. F., T. Gussinklo, P. J. Arts, B. A. Van Oost & H. J. Smeets: A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples. J Neurol Sci, 149, 37-40(1997)
doi:10.1016/S0022-510X(97)05366-5
PMid:9168163

16. van Den Bosch, B. J., R. F. de Coo, H. R. Scholte, J. G. Nijland, R. van Den Bogaard, M. de Visser, C. E. de Die-Smulders & H. J. Smeets: Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res, 28, E89(2000)
doi:10.1093/nar/28.20.e89

17. Xiao, W. & P. J. Oefner: Denaturing high-performance liquid chromatography: A review. Hum Mutat, 17, 439-74(2001)
doi:10.1002/humu.1130
PMid:11385705

18. Mambo, E., X. Gao, Y. Cohen, Z. Guo, P. Talalay & D. Sidransky: Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci U S A, 100, 1838-43(2003)
doi:10.1073/pnas.0437910100

19. Bielas, J. H. & L. A. Loeb: Quantification of random genomic mutations. Nat Methods, 2, 285-90(2005)
doi:10.1038/nmeth751
PMid:15782221

20. Vermulst, M., J. H. Bielas & L. A. Loeb: Quantification of random mutations in the mitochondrial genome. Methods, 46, 263-8(2008)
doi:10.1016/j.ymeth.2008.10.008
PMid:18948200

21. Saugstad, O. D., S. Ramji & M. Vento: Oxygen for newborn resuscitation: how much is enough? Pediatrics, 118, 789-92(2006)
doi:10.1542/peds.2006-0832
PMid:16882835

22. Escrig, R., L. Arruza, I. Izquierdo, G. Villar, P. Saenz, A. Gimeno, M. Moro & M. Vento: Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics, 121, 875-81(2008)
doi:10.1542/peds.2007-1984
PMid:18450889

23. Saugstad, O. D.: Optimal oxygenation at birth and in the neonatal period. Neonatology, 91, 319-22(2007)
doi:10.1159/000101349
PMid:17575477

24. Vento, M., M. Asensi, J. Sastre, F. Garcia-Sala, F. V. Pallardo & J. Vina: Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics, 107, 642-7(2001)
doi:10.1542/peds.107.4.642
PMid:11335737

25. Maruyama, K., H. Ikeda, T. Koizumi, Y. Tsuchida, M. Tanimura, H. Nishida, N. Takahashi, M. Fujimura & Y. Tokunaga: Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight. Pediatr Int, 42, 492-8(2000)
doi:10.1046/j.1442-200x.2000.01287.x
PMid:11059537

26. Spector, L. G., M. A. Klebanoff, J. H. Feusner, M. K. Georgieff & J. A. Ross: Childhood cancer following neonatal oxygen supplementation. J Pediatr, 147, 27-31(2005)
doi:10.1016/j.jpeds.2005.03.008
PMid:16027689

27. Suematsu, N., H. Tsutsui, J. Wen, D. Kang, M. Ikeuchi, T. Ide, S. Hayashidani, T. Shiomi, T. Kubota, N. Hamasaki & A. Takeshita: Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation, 107, 1418-23(2003)
doi:10.1161/01.CIR.0000055318.09997.1F
PMid:12642364

28. Maniscalco, W. M., R. H. Watkins, J. M. Roper, R. Staversky & M. A. O'Reilly: Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr Res, 58, 549-56(2005)
doi:10.1203/01.pdr.0000176923.79584.f7
PMid:16148072

30. Lee, J., R. Reddy, L. Barsky, K. Weinberg & B. Driscoll: Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. Am J Physiol Lung Cell Mol Physiol, 290, L685-L694(2006)
doi:10.1152/ajplung.00020.2005
PMid:16299057

31. Roper, J. M., D. J. Mazzatti, R. H. Watkins, W. M. Maniscalco, P. C. Keng & M. A. O'Reilly: In vivo exposure to hyperoxia induces DNA damage in a population of alveolar type II epithelial cells. Am J Physiol Lung Cell Mol Physiol, 286, L1045-54(2004)
doi:10.1152/ajplung.00376.2003

32. Barker, G. F., N. D. Manzo, K. L. Cotich, R. K. Shone & A. B. Waxman: DNA damage induced by hyperoxia: quantitation and correlation with lung injury. Am J Respir Cell Mol Biol, 35, 277-88(2006)
doi:10.1165/rcmb.2005-0340OC
PMid:16574945    PMCid:2643280

33. Tsukahara, H., M. Z. Jiang, N. Ohta, S. Sato, S. Tamura, M. Hiraoka, M. Maeda & M. Mayumi: Oxidative stress in neonates: evaluation using specific biomarkers. Life Sci, 75, 933-8(2004)
doi:10.1016/j.lfs.2004.01.025
PMid:15193953

34. O'Donovan, D. J. & C. J. Fernandes: Mitochondrial glutathione and oxidative stress: implications for pulmonary oxygen toxicity in premature infants. Mol Genet Metab, 71, 352-8(2000)
doi:10.1006/mgme.2000.3063
PMid:11001827

35. Buonocore, G., S. Perrone & R. Bracci: Free radicals and brain damage in the newborn. Biol Neonate, 79, 180-6(2001)
doi:10.1159/000047088
PMid:11275648

36. Tsutsui, H.: Mitochondrial oxidative stress and heart failure. Intern Med, 45, 809-13(2006)
doi:10.2169/internalmedicine.45.1765
PMid:16880705

37. Ricci, C., V. Pastukh, J. Leonard, J. Turrens, G. Wilson, D. Schaffer & S. W. Schaffer: Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol, 294, C413-22(2008)
doi:10.1152/ajpcell.00362.2007
PMid:18077603

38. Collins, L. V., S. Hajizadeh, E. Holme, I. M. Jonsson & A. Tarkowski: Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol, 75, 995-1000(2004)
doi:10.1189/jlb.0703328
PMid:14982943

Abbreviations: BAL: bronchoalveolar lavage; mtDNA: mitochondrial DNA; ROS: reactive oxygen species

Key Words: Prematurity, Mechanical ventilation, Oxidant stress, Lung injury, Mitochondrial DNA

Send correspondence to: Eduardo Villamor, Dept of Pediatrics, Maastricht University Medical Centre (MUMC+), P. Debyelaan 25 P.O. Box 5800 6202 AZ Maastricht, The Netherlands, Tel: 31-43-3877246, Fax: 31-43-3875246, E-mail: e.villamor@mumc.nl